CIK 0001527753
- Non-accelerated filer
- Smaller reporting company
Personalis, Inc.
Sign in to watch- Ticker
- PSNL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275411038
- Phone
- +1 650-752-1300
- Business address
- 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
- 4 Open-market sale Chief Scientific Officer sold 1,101 shares at $22.75 ($25,048)
- 4 Grant or award President and CEO acquired 75,000 shares (grant or award)
- 4 Open-market sale President and CEO sold 110,000 shares at an average $22.43 ($2,467,273)
- 4 Open-market sale Chief Financial Officer sold 2,899 shares at $21.57 ($62,531)
- 4 Open-market sale Chief Scientific Officer sold 291 shares at $21.57 ($6,277)
- 4 Grant or award Director acquired 2,736 shares (grant or award)
- 4 Grant or award Director acquired 2,736 shares (grant or award)
- 4 Grant or award Director acquired 2,736 shares (grant or award)
- 4 Grant or award Director acquired 2,736 shares (grant or award)
- 4 Grant or award Director acquired 2,736 shares (grant or award)
- 4 Grant or award Director acquired 2,736 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 53,750 shares (grant or award)
- 4 Open-market sale Chief Scientific Officer sold 40,000 shares at an average $25.69 ($1,027,592)
- 4 Open-market sale Chief Scientific Officer sold 1,130 shares at $26.73 ($30,205)
- 4 Open-market sale Chief Financial Officer sold 2,446 shares at $26.73 ($65,382)
- 4 Grant or award Director acquired 2,610 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 3,022 shares at $32.60 ($98,517)
Page 11 of 15 · 289 filings